Clearstead Advisors’s CONMED CNMD Stock Holding History

Clearstead Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.02K	Buy	+31	New	+$1.12K	﹤0.01%	2680
2025 Q3	–	Sell	-2,500	Closed	-$130K	–	3125
2025 Q2	$130K	Hold	2,500	–	–	﹤0.01%	989
2025 Q1	$151K	Sell	2,500 -71	-3%	-$4.58K	﹤0.01%	893
2024 Q4	$176K	Sell	2,571 -20	-0.8%	-$1.39K	﹤0.01%	891
2024 Q3	$186K	Hold	2,591	–	–	﹤0.01%	877
2024 Q2	$180K	Buy	2,591 +2,543	+5,298%	+$186K	﹤0.01%	846
2024 Q1	$3.5K	Hold	48	–	–	﹤0.01%	1230
2023 Q4	$5.26K	Buy	48 +22	+85%	+$2.27K	﹤0.01%	1159
2023 Q3	$2.62K	Buy	+26	New	+$2.99K	﹤0.01%	1193

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Clearstead Advisors's CNMD Position: Q2 2026 in Review

Clearstead Advisors opened a new position in CONMED (CNMD) in Q2 2026: 31 shares worth $1.02K. The stake represents ﹤0.01% of the portfolio and ranks #2680 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in CNMD as recently as Q2 2025.

Clearstead Advisors first reported a position in CNMD in Q3 2023 and has held it in 9 quarters since. The position peaked at $186K in Q3 2024. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Clearstead Advisors held 31 shares of CONMED worth $1.02K as of Q2 2026.
CONMED was a new Clearstead Advisors position in Q2 2026.
CONMED made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2680 holding.
Clearstead Advisors first reported a position in CONMED in Q3 2023 and has held it in 9 quarters since.
Clearstead Advisors's CONMED position peaked at $186K in Q3 2024.
247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.